These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 9481891)

  • 21. Serologic tests for connective tissue diseases and the primary vasculitides.
    Warner NB
    Dermatol Clin; 1994 Jan; 12(1):161-73. PubMed ID: 8143379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ANF-associated diseases ( lecture)].
    Ivanova SM; Speranskiĭ AI
    Klin Lab Diagn; 2003 Oct; (10):23-34. PubMed ID: 14663880
    [No Abstract]   [Full Text] [Related]  

  • 23. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of the dense fine speckled pattern and anti-DFS70 antibodies for the diagnosis of systemic autoimmune rheumatic diseases].
    López Sañudo S; Fernández Alonso I; López Hoyos M
    Med Clin (Barc); 2015 Sep; 145(5):218-23. PubMed ID: 26021571
    [No Abstract]   [Full Text] [Related]  

  • 25. Specificity and sensitivity of antinuclear and anticytoplasmic antibodies in the diagnosis and follow-up of systemic diseases.
    Gioud M
    Clin Rheumatol; 1987 Jun; 6 Suppl 1():27-33. PubMed ID: 3497763
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases.
    Wiik AS
    Scand J Rheumatol; 2005; 34(4):260-8. PubMed ID: 16195158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of antinuclear antibody connective tissue disease screen.
    López-Hoyos M; Rodríguez-Valverde V; Martinez-Taboada V
    Ann N Y Acad Sci; 2007 Aug; 1109():322-9. PubMed ID: 17785321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of antibodies against extractable nuclear antigens].
    Genth E
    Med Welt; 1982 Nov; 33(45):1583-91. PubMed ID: 6757641
    [No Abstract]   [Full Text] [Related]  

  • 29. Laboratory screening of connective tissue diseases by a new automated ENA screening assay (EliA Symphony) in clinically defined patients.
    González C; García-Berrocal B; Pérez M; Navajo JA; Herraez O; González-Buitrago JM
    Clin Chim Acta; 2005 Sep; 359(1-2):109-14. PubMed ID: 15894301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The variability of immunologic laboratory tests.
    Feigenbaum PA; Medsger TA; Kraines RG; Fries JF
    J Rheumatol; 1982; 9(3):408-14. PubMed ID: 6811741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies targeting extractable nuclear antigens: historical development and current knowledge.
    Wenzel J; Gerdsen R; Uerlich M; Bauer R; Bieber T; Boehm I
    Br J Dermatol; 2001 Dec; 145(6):859-67. PubMed ID: 11899137
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnostic difficulties in polymyositis].
    Majewski D; Puszczewicz M; Tuchocka-Piotrowska A; Kołczewska A
    Ann Acad Med Stetin; 2006; 52 Suppl 2():45-8. PubMed ID: 17474177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The spectrum of antinuclear and anticytoplasmatic antibodies in collagenoses].
    Meurer M; Ring J
    Hautarzt; 1980 Sep; 31(9):478-85. PubMed ID: 6969717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunofluorescence assay for antinuclear factor: a nonspecific test in hospitalized medical patients.
    Borak J; Vasey F; Lauter S; Dorval G; Osterland CK
    Can Med Assoc J; 1979 Nov; 121(10):1372-4. PubMed ID: 391378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinuclear antibodies: clinical applications.
    Wanchu A
    J Postgrad Med; 2000; 46(2):144-8. PubMed ID: 11013488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Finger joint calcinosis followed by osteolysis in a patient with multisystem connective tissue disease and anti-Jo-1 antibody.
    Cohen MG; Ho KK; Webb J
    J Rheumatol; 1987 Jun; 14(3):605-8. PubMed ID: 3498039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibodies to soluble nuclear antigens and native DNA in patients with connective tissue diseases with antinuclear antibodies].
    Damilano G; Hübscher O; Fernández L; Arana RM
    Medicina (B Aires); 1983; 43(5):488-94. PubMed ID: 6371438
    [No Abstract]   [Full Text] [Related]  

  • 38. [Preliminary report on the clinical application of anti-Jo-1 antibody].
    Dong Y; Cheng PC; Zhang NC
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of autoantigens and clinical significance of antinuclear antibodies].
    Mimori T; Matsumura M; Ishida M; Takahashi Y; Hirakata M; Ohosone Y
    Rinsho Byori; 1998 Apr; 46(4):303-10. PubMed ID: 9594619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of serologic methods for the determination of antinuclear factors and their differential-diagnostic significance].
    Apostoloff E; Apostoloff G; Sönnichsen N; Nebe H
    Dtsch Gesundheitsw; 1967 Jun; 22(23):1060-5. PubMed ID: 5302966
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.